The New York Times - Business:
With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.
This post first appeared in The New York Times - Business. Read the original article.
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.
